Dipyrone and blood dyscrasia revisited

“non-evidence based medicine”

Autores

  • Isabela M. Benseñor Universidade de São Paulo

Downloads

Não há dados estatísticos.

Biografia do Autor

Isabela M. Benseñor, Universidade de São Paulo

Assistant professor in the Division of Clinical Medicine, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Referências

Hamerschlak N, Maluf E, Paquini R, et al. LATIN study – Incidence of aplastic anemia and agranulocytosis in Latin America. Sao Paulo Med J. 2005;123(3):101-4.

Shapiro S, Issaragrisil S, Kaufman DW, et al. Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group. Am J Trop Med Hyg. 1999;60(4):573-7.

van der Klauw MM, Goudsmit R, Halie MR, et al. A popula- tion-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med. 1999;159(4):369-74.

Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study. JAMA. 1986;256(13):1749-57.

Dorr VJ, Cook J. Agranulocytosis and near fatal sepsis due to “Mexican aspirin” (dipyrone). South Med J. 1996;89(6):612-4.

Hargis JB, La Russa VF, Redmond J, Kessler SW, Wright DG. Agranulocytosis associated with “Mexican aspirin” (dipyrone): evidence for an autoimmune mechanism affecting multipotential hematopoietic progenitors. Am J Hematol. 1989;31(3):213-5.

Benseñor IM. To use or not to use dipyrone? Or maybe, Cen- tral Station versus ER? That is the question. Sao Paulo Med J. 2001;119(6):190-1.

Edwards JE, McQuay HJ. Dipyrone and agranulocytosis: what is the risk? Lancet. 2002;360(9344):1438.

Hawton K. United Kingdom legislation on pack sizes of analge- sics: background, rationale, and effects on suicide and deliberate self-harm. Suicide Life Threat Behav. 2002;32(3):223-9.

Townsend E, Hawton K, Harriss L, Bale E, Bond A. Substances used in deliberate self-poisoning 1985-1997: trends and associations with age, gender, repetition and suicide intent. Soc Psychiatry Psychiatr Epidemiol. 2001;36(5):228-34.

Cranney M, Cranney J, Stubbs H. Limitation of over the coun- ter sales of paracetamol. Packaging policy is unlikely to achieve its aim of reducing suicide. BMJ. 1998;317(7173):1657.

Neeleman J, Wessely S. Drugs taken in fatal and non-fatal self-poisoning: a study in south London. Acta Psychiatr Scand. 1997;95(4):283-7.

Skarupski KA, Mrvos R, Krenzelok EP. A profile of calls to a poison information center regarding older adults. J Aging Health. 2004;16(2):228-47.

Lo A, Shalansky S, Leung M, Hollander Y, Raboud J. Patient characteristics associated with nonprescription drug use in intentional overdose. Can J Psychiatry. 2003;48(4):232-6.

Downloads

Publicado

2005-05-05

Como Citar

1.
Benseñor IM. Dipyrone and blood dyscrasia revisited: “non-evidence based medicine”. Sao Paulo Med J [Internet]. 5º de maio de 2005 [citado 16º de outubro de 2025];123(3):99-100. Disponível em: https://periodicosapm.emnuvens.com.br/spmj/article/view/2330

Edição

Seção

Editorial